← Leaderboards
Kathryn Haskins
University Of Colorado Denver
$12,584,495
Attributed
$14,125,232
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,125,232 · 10
By mechanism
R01$11,310,740 · 4
R21$1,419,770 · 3
T32$1,302,322 · 2
R56$92,400 · 1
Top collaborators
- Richard Kp Benninger6 shared
- Eddie A James4 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Aaron W Michels$8,254,447
- Jill M Norris$16,405,166
- V Michael Holers$38,234,826
- David H Wagner$7,807,688
- Rocky Lee Baker$2,368,600
Others in their field
Top investigators on “Autoantigens”
- Alessandro Sette · La Jolla Institute For Immunology$40,540,354
- V Michael Holers · University Of Colorado Denver$24,567,150
- Merrill E Gershwin · University Of California At Davis$15,896,665
- Patrick M Gaffney · University Of Minnesota Twin Cities$14,889,699
- Mark S Anderson · University Of California, San Francisco$14,724,222
- Ali Naji · University Of Pennsylvania$13,417,221
Research focus
AutoantigensCd4 Positive T LymphocytesPathogenesisT-LymphocyteInsulin-Dependent Diabetes MellitusAntigensDiabetes MellitusInbred Nod MiceIsletInflammatoryPeptidesProteinsPathogenicityBeta CellGenerationsIn VivoAutoreactive T CellAntigen TargetingAutoimmune ProcessHybridsClone CellsC-PeptideInsulinDesign
Grant awards (41)
Interdisciplinary Bioengineering Research Training in Diabetes$212,204
T32 · FY2025 · DK
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells$488,370
R01 · FY2024 · DK · contact PI
Interdisciplinary Bioengineering Research Training in Diabetes$182,974
T32 · FY2024 · DK
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells$508,719
R01 · FY2023 · DK · contact PI
Interdisciplinary Bioengineering Research Training in Diabetes$177,693
T32 · FY2023 · DK
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells$508,719
R01 · FY2022 · DK · contact PI
T cell repertoire for hybrid insulin peptides$492,710
R01 · FY2022 · DK · contact PI
Interdisciplinary Bioengineering Research Training in Diabetes$190,202
T32 · FY2022 · DK
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells$522,594
R01 · FY2021 · DK · contact PI
T cell repertoire for hybrid insulin peptides$492,710
R01 · FY2021 · DK · contact PI
Interdisciplinary Bioengineering Research Training in Diabetes$194,076
T32 · FY2021 · DK
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells$580,710
R01 · FY2020 · DK · contact PI
T cell repertoire for hybrid insulin peptides$492,710
R01 · FY2020 · DK · contact PI
Interdisciplinary Bioengineering Research Training in Diabetes$95,923
T32 · FY2020 · DK
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells$580,710
R01 · FY2019 · DK · contact PI
T cell repertoire for hybrid insulin peptides$500,855
R01 · FY2019 · DK · contact PI
Autoantibodies to hybrid insulin peptides in type 1 diabetes$233,250
R21 · FY2019 · AI · contact PI
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells$580,710
R01 · FY2018 · DK · contact PI
Autoantibodies to hybrid insulin peptides in type 1 diabetes$194,375
R21 · FY2018 · AI · contact PI
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells$553,829
R01 · FY2017 · DK · contact PI
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells$567,704
R01 · FY2016 · DK · contact PI
Role of T Cells Specific for Citrullinated Fibrinogen in Rheumatoid Arthritis$171,050
R21 · FY2016 · AR · contact PI
Autoantigens for Diabetogenic CD4 T Cells$474,915
R01 · FY2015 · DK · contact PI
Role of T Cells Specific for Citrullinated Fibrinogen in Rheumatoid Arthritis$205,095
R21 · FY2015 · AR · contact PI
Autoantigens for Diabetogenic CD4 T Cells$474,915
R01 · FY2014 · DK · contact PI
Autoantigens for Diabetogenic CD4 T Cells$458,292
R01 · FY2013 · DK · contact PI
Autoantigens for Diabetogenic CD4 T Cells$474,915
R01 · FY2012 · DK · contact PI
Autoantigens for Diabetogenic CD4 T Cells$483,129
R01 · FY2011 · DK · contact PI
Effector Function of Autoreactive Th1 T Cells$8,000
R01 · FY2010 · DK · contact PI
Effector Function of Autoreactive Th1 T Cells$294,889
R01 · FY2009 · DK · contact PI
Effector Function of Autoreactive Th1 T Cells$295,050
R01 · FY2008 · DK · contact PI
Effector Function of Autoreactive Th1 T Cells$301,231
R01 · FY2007 · DK · contact PI
Effector Function of Autoreactive Th1 T Cells$310,386
R01 · FY2006 · DK · contact PI
Proteomics Analysis of T Cell Autoantigens in TID2$308,000
R21 · FY2005 · AI
Effector Function of Autoreactive Th1 T Cells$92,400
R56 · FY2005 · DK
Proteomics Analysis of T Cell Autoantigens in TID2$308,000
R21 · FY2004 · AI
Autoreactive T Cells in NOD TCR Transgenic Mice$207,963
R01 · FY2004 · DK
Autoreactive T Cells in NOD TCR Transgenic Mice$206,022
R01 · FY2003 · DK
Autoreactive T Cells in NOD TCR Transgenic Mice$205,001
R01 · FY2002 · DK
TRAINING PROGRAM IN IMMUNOLOGY$249,250
T32 · FY2000 · AI
IMMUNOREGULATION IN THE NOD MOUSE$244,982
R01 · FY2000 · AI